...
首页> 外文期刊>BMC Anesthesiology >Effect of propofol and sevoflurane on the inflammatory response of patients undergoing craniotomy
【24h】

Effect of propofol and sevoflurane on the inflammatory response of patients undergoing craniotomy

机译:丙泊酚和七氟醚对开颅手术患者炎症反应的影响

获取原文
           

摘要

Background The purpose of this randomised, single-centre study was to prospectively investigate the impact of anaesthetic techniques for craniotomy on the release of cytokines IL-6, IL-8, IL-10, and to determine whether intravenous anaesthesia compared to inhalational anaesthesia attenuates the inflammatory response. Methods The study enroled 40 patients undergoing craniotomy, allocated into two equal groups to receive either sevoflurane ( n =?20) or propofol ( n =?20) in conjunction with remifentanil and rocuronium. The lungs were ventilated mechanically to maintain normocapnia. Remifentanil infusion was adjusted according to the degree of surgical manipulation and increased when mean arterial pressure and the heart rate increased by more than 30?% from baseline. The depth of anaesthesia was adjusted to maintain a bispectral index (BIS) of 40–60. Invasive haemodynamic monitoring was used. Serum levels of IL-6, IL-8 and IL-10 were measured before surgery and anaesthesia, during tumour removal, at the end of surgery, and at 24 and 48?h after surgery. Postoperative complications (pain, vomiting, changes in blood pressure, infection and pulmonary, cardiovascular and neurological events) were monitored during the first 15?days after surgery. Results Compared with patients anaesthetised with sevoflurane, patients who received propofol had higher levels of IL-10 ( p =?0.0001) and lower IL-6/IL-10 concentration ratio during and at the end of surgery ( p =?0.0001). Both groups showed only a minor response of IL- 8 during and at the end of the surgery ( p =?0.57). Conclusions Patients who received propofol had higher levels of IL-10 during surgery. Neither sevoflurane nor propofol had any significant impact on the occurrence of postoperative complications. Our findings should incite future studies to prove a potential medically important anti-inflammatory role of propofol in neuroanaesthesia. Clinical trial registration Identified as NCT02229201 at www.?clinicaltrials.?gov
机译:背景这项随机,单中心研究的目的是前瞻性研究开颅麻醉技术对细胞因子IL-6,IL-8,IL-10释放的影响,并确定静脉麻醉与吸入麻醉相比是否减弱炎症反应。方法该研究招募了40例行开颅手术的患者,分为两组,分别接受七氟醚(n = 20)或丙泊酚(n = 20)联合瑞芬太尼和罗库溴铵。机械肺通气以维持正常碳酸血症。根据手术操作的程度调整瑞芬太尼的输注量,当平均动脉压和心率比基线增加30%以上时,瑞芬太尼的输注量会增加。调整麻醉深度以保持40-60的双光谱指数(BIS)。使用有创血流动力学监测。在手术和麻醉前,切除肿瘤期间,手术结束时以及手术后24和48小时,测量血清IL-6,IL-8和IL-10的水平。术后头15天内监测术后并发症(疼痛,呕吐,血压变化,感染以及肺,心血管和神经系统事件)。结果与使用七氟醚麻醉的患者相比,接受异丙酚的患者在手术期间和手术结束时具有更高的IL-10水平(p =?0.0001)和更低的IL-6 / IL-10浓度比(p =?0.0001)。两组在手术期间和手术结束时仅显示出较小的IL-8反应(p =?0.57)。结论接受丙泊酚的患者在手术期间具有较高的IL-10水平。七氟醚和丙泊酚对术后并发症的发生均无显着影响。我们的发现应激发未来的研究,以证明异丙酚在神经麻醉中具有潜在的医学上重要的抗炎作用。临床试验注册在www.?clinicaltrials.?gov上标识为NCT02229201

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号